SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Non-current Assets
All assets not expected to be converted to cash within one year.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets of $5.02M in Q1 FY2026
Q1 FY2026 total non-current assets was $5.02M.
Context
- Total non-current assets amounted to 1.9% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 7.1M USD
- Year-over-year change
- —
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.1M | — |
Total Non-current Assets vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
- Total non-current assets amounts to 1.9% of total assets for SGP, versus a peer median of 13.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $24.39B USD | -3.1% | +1.5% | 77.8% | |
| Jun 2026 | $10.94B USD | -0.4% | +7.0% | 78.9% | |
| Jun 2026 | $404.74M USD | -26.5% | -12.8% | 44.0% | |
| Apr 2026 | $138.72M USD | +6.0% | +11.9% | 30.8% | |
| Mar 2026 | $38.71M USD | +8.8% | +67.3% | 13.4% | |
| Mar 2026 | $26.53M USD | +45.6% | +9.7% | 3.6% | |
| Mar 2026 | $24.77M USD | +0.6% | +16.0% | 8.1% | |
| Mar 2026 | CHF 16.91M CHF | +9.9% | +8.4% | 6.9% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $5.02M USD | — | — | 1.9% |
| Mar 2026 | $3.19M USD | +15.0% | -8.9% | 2.9% | |
| Peer median (excluding SGP) | — | +6.0% | +8.4% | 13.4% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.